1 Min Read
June 1 (Reuters) - SPECTRACURE AB (PUBL):
* CANADIAN PATENT OFFICE APPROVED PATENT FOR DOSE CONTROL IN A TECHNOLOGY AIMED TO CURE PROSTATE CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.